1. Assan, R., Feutren, G., Debray-Sachs, M., Quiniou-Debrie, M. C., Laborie, C., Thomas, G., Chatenoud, M., and Bach, J. E., 1985, Metabolie and immunological effects of cyclosporin in recently diagnosed type 1 diabetes mellitus, Lancet 1:67–71.
2. Autenried, P., and Halloran, P. E., 1985, Cyclosporine blocks the induction of Class I and Class IIMHC products in mouse kidney by Graft-VS-Host disease, J. Immunol. 135:3922–3928.
3. Bach, J. E., 1988, Mechanisms of autoimmunity in insulin-dependent diabetes mellitus, Clin. Exp. Immunol. 72:1–8.
4. Ben Ezra, D., 1986, Cyclosporin A in Behçet’s disease—An overview, in: Recent Advances in Behget’s Disease (T. Lehner and C. G. Barnes, eds.), Royal Society of Medical Service, London, pp. 319–325.
5. Ben Ezra, D., Cohen, E., Rakotomalala, M., de Courten, C., Harris, W., Chajek, T., Friedman, G., and Matamoros, N., 1988a, Treatment of endogenous uveitis with cyclosporin A, Transplant. Proc. 20(Suppl. 4):122–127.